Publication

Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Colleen E. Keohane, Emory UniversityAndrew D. Steele, Emory UniversityChristian Fetzer, Technical University of MunichJittasak Khowsathit, Fox Chase Cancer CenterDaria Van Tyne, Harvard Medical SchoolLucile Maynie, University of OxfordMichael S. Gilmore, Harvard Medical SchoolJohn Karanicolas, Fox Chase Cancer CenterStephan A. Sieber, Technical University of MunichWilliam Wuest, Emory University
Language
  • English
Date
  • 2018-02-07
Publisher
  • American Chemical Society
Publication Version
Copyright Statement
  • © 2018 American Chemical Society.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0002-7863
Volume
  • 140
Issue
  • 5
Start Page
  • 1774
End Page
  • 1782
Grant/Funding Information
  • This work was supported by the National Science Foundation CHE1755698(W.M.W.), the National Institute of General Medical Studies R35 GM119426 (W.M.W.), and Temple University. D.V.T. is supported by Grant EY028222 from the National Eye Institute.
  • Computational resources were provided through National Science Foundation XSEDE allocation MCB130049.
Supplemental Material (URL)
Abstract
  • Natural products have served as an inspiration to scientists both for their complex three-dimensional architecture and exquisite biological activity. Promysalin is one such Pseudomonad secondary metabolite that exhibits narrow-spectrum antibacterial activity, originally isolated from the rhizosphere. We herein utilize affinity-based protein profiling (AfBPP) to identify succinate dehydrogenase (Sdh) as the biological target of the natural product. The target was further validated in silico, in vitro, in vivo, and through the selection, and sequencing, of a resistant mutant. Succinate dehydrogenase plays an essential role in primary metabolism of Pseudomonas aeruginosa as the only enzyme that is involved both in the tricarboxylic acid cycle (TCA) and in respiration via the electron transport chain. These findings add credence to other studies that suggest that the TCA cycle is an understudied target in the development of novel therapeutics to combat P. aeruginosa, a significant pathogen in clinical settings.
Author Notes
Keywords
Research Categories
  • Chemistry, Physical

Tools

Relations

In Collection:

Items